Literature DB >> 16023816

A new approach in the prediction of the dissolution behavior of suspended particles by means of their particle size distribution.

A P Tinke1, K Vanhoutte, R De Maesschalck, S Verheyen, H De Winter.   

Abstract

Though various attempts have been made in literature to model the particle size distribution of an active pharmaceutical ingredient (API) in function of the required release profile of the pharmaceutical product, so far one has not succeeded to develop a universal approach in the correlation of particle size distribution and in vitro dissolution data. In this publication, a new approach is presented on the use of particle size distribution data in the prediction of the in vitro dissolution profile of a suspension formulation. For this purpose, various theoretical experiments were done simply on paper and based on the Noyes-Whitney [A.A. Noyes, W.R. Whitney, J. Am. Chem. Soc. 19 (1897) 930-934] equation, the normalized dissolution profiles of various imaginary size distributions were calculated. For each size distribution, its weighted mean diameters were then calculated. Based on these theoretical data, a model could be developed which scientifically explains the dissolution profile of a suspension in function of its volume-weighted mean particle size (D[4, 3]). The applicability of this correlation model could experimentally be confirmed by evaluation of laser diffraction and in vitro dissolution data as they were obtained for different batches of a suspension formulation. This new approach in the correlation between particle size and dissolution may be an important analytical tool in the engineering of the particle size distribution of drug substance, and more precisely monitoring the D[4, 3] volume-weighted mean diameter may allow one to model the dissolution profile of a suspension formulation and thereby its in vivo release profile.

Mesh:

Substances:

Year:  2005        PMID: 16023816     DOI: 10.1016/j.jpba.2005.05.014

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  10 in total

1.  Development of a new method to assess nanocrystal dissolution based on light scattering.

Authors:  Katharina Anhalt; Simon Geissler; Meike Harms; Markus Weigandt; Gert Fricker
Journal:  Pharm Res       Date:  2012-06-12       Impact factor: 4.200

2.  A modified approach to predict dissolution and absorption of polydisperse powders.

Authors:  John C Butcher; Sanjay Garg; Dawoomi Kim; Puneet Sharma
Journal:  Pharm Res       Date:  2008-06-04       Impact factor: 4.200

3.  Powder dissolution method for estimating rotating disk intrinsic dissolution rates of low solubility drugs.

Authors:  Konstantin Tsinman; Alex Avdeef; Oksana Tsinman; Dmytro Voloboy
Journal:  Pharm Res       Date:  2009-06-19       Impact factor: 4.200

4.  Formulation and evaluation of a salted-out isoniazid-loaded nanosystem.

Authors:  Lisa C du Toit; Viness Pillay; Yahya E Choonara; Sunny E Iyuke
Journal:  AAPS PharmSciTech       Date:  2008-01-25       Impact factor: 3.246

5.  Defining drug and target protein distributions after stent-based drug release: Durable versus deployable coatings.

Authors:  Abraham R Tzafriri; Fernando Garcia-Polite; Xiaojian Li; John Keating; Josep-Maria Balaguer; Brett Zani; Lynn Bailey; Peter Markham; Timothy C Kiorpes; Wenda Carlyle; Elazer R Edelman
Journal:  J Control Release       Date:  2018-02-05       Impact factor: 9.776

6.  Manufacturing nanosized fenofibrate by salt assisted milling.

Authors:  Vadym N Mochalin; Adarsh Sagar; Shruti Gour; Yury Gogotsi
Journal:  Pharm Res       Date:  2009-02-18       Impact factor: 4.200

7.  A Systematic Approach in the Development of the Morphologically-Directed Raman Spectroscopy Methodology for Characterizing Nasal Suspension Drug Products.

Authors:  Gonçalo Farias; Jagdeep Shur; Robert Price; Elizabeth Bielski; Bryan Newman
Journal:  AAPS J       Date:  2021-05-18       Impact factor: 4.009

8.  Nanoscale hepatoprotective herbal decoction attenuates hepatic stellate cell activity and chloroform-induced liver damage in mice.

Authors:  Sherry Huang; Shu-Jen Chang; Miffy Yang; Justin Jin-Ching Chen; Walter H Chang
Journal:  Int J Nanomedicine       Date:  2011-07-01

9.  Dissolution Kinetics of a BCS Class II Active Pharmaceutical Ingredient: Diffusion-Based Model Validation and Prediction.

Authors:  Yuan Gao; Brian Glennon; Yunliang He; Philip Donnellan
Journal:  ACS Omega       Date:  2021-03-19

10.  Stepwise dissolution and composition determination of samples of multiple crystals using a dissolution medium containing aqueous alcohol and fluorocarbon phases.

Authors:  Humphrey A Moynihan; Declan Armstrong
Journal:  RSC Adv       Date:  2019-07-09       Impact factor: 4.036

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.